Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

The tetravalent dengue vaccine strain (TV003/TV005) originally developed by the National Institutes of Health, the U.S., has shown promising results in preclinical and clinical trials worldwide. Representational File Image |…

Continue ReadingEnrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR